Pluristem Therapeutics ( PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. This stock is trading up 12.3% at $4.00 in recent trading. Today's Range: $3.75-$4.20 52-Week Range: $1.98-$4.23 Volume: 2.4 million Three-Month Average Volume: 531,278 >>7 Stocks Soaring on Heavy Volume From a technical perspective, PSTI is gapping up sharply here right off some near-term support at $3.51 with heavy volume. This move is quickly pushing PSTI within range of triggering a major breakout trade. That trade will trigger once PSTI takes out some key overhead resistance at $4.23 to $4.38 with high volume. Traders should now look for long-biased trades in PSTI as long as this stock is trending above $3.50, and then once it clears $4.23 to $4.38 with high volume. Look for a sustained move or close above those levels with volume that's near or above 531,278 shares. If that major breakout triggers soon, then PSTI has a chance to head well north of $5 in the near future. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Complete Genomics (Nasdaq:GNOM) is trading at unusually high volume Tuesday with 5.6 million shares changing hands. It is currently at four times its average daily volume and trading down 23 cents (-7.7%).